Header Logo

Connection

Ajaypal Singh to Biosimilar Pharmaceuticals

Back to Details
This is a "connection" page, showing publications Ajaypal Singh has written about Biosimilar Pharmaceuticals.
Ajaypal Singh
Connection Strength
0.160
Biosimilar Pharmaceuticals
  1. A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease. Am J Nephrol. 2017; 46(5):364-370.
    View in: PubMed
    Score: 0.160
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.